Accretive Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
3,248
+41
| +1% | +$16.6K | 0.43% | 73 |
|
|
2025
Q1 | $1.31M | Buy |
3,207
+331
| +12% | +$135K | 0.46% | 69 |
|
|
2024
Q4 | $1.5M | Buy |
2,876
+2,279
| +382% | +$1.19M | 0.64% | 54 |
|
|
2024
Q3 | $369K | Sell |
597
-29
| -5% | -$17.9K | 0.15% | 111 |
|
|
2024
Q2 | $346K | Hold |
626
| – | – | 0.14% | 114 |
|
|
2024
Q1 | $358K | Sell |
626
-14
| -2% | -$8.01K | 0.16% | 115 |
|
|
2023
Q4 | $340K | Buy |
640
+48
| +8% | +$25.5K | 0.16% | 113 |
|
|
2023
Q3 | $300K | Hold |
592
| – | – | 0.18% | 106 |
|
|
2023
Q2 | $309K | Buy |
592
+6
| +1% | +$3.13K | 0.18% | 101 |
|
|
2023
Q1 | $338K | Buy |
586
+3
| +0.5% | +$1.73K | 0.22% | 100 |
|
|
2022
Q4 | $321K | Buy |
583
+175
| +43% | +$96.4K | 0.22% | 99 |
|
|
2022
Q3 | $207K | Hold |
408
| – | – | 0.16% | 101 |
|
|
2022
Q2 | $222K | Sell |
408
-8
| -2% | -$4.35K | 0.16% | 103 |
|
|
2022
Q1 | $246K | Hold |
416
| – | – | 0.15% | 102 |
|
|
2021
Q4 | $278K | Sell |
416
-9
| -2% | -$6.01K | 0.18% | 99 |
|
|
2021
Q3 | $243K | Buy |
425
+26
| +7% | +$14.9K | 0.17% | 101 |
|
|
2021
Q2 | $201K | Sell |
399
-71
| -15% | -$35.8K | 0.14% | 107 |
|
|
2021
Q1 | $214K | Sell |
470
-30
| -6% | -$13.7K | 0.19% | 95 |
|
|
2020
Q4 | $233K | Buy |
+500
| New | +$233K | 0.23% | 92 |
|